Literature DB >> 7701041

Nicotine discrimination in male and female smokers.

K A Perkins1, A DiMarco, J E Grobe, A Scierka, R L Stiller.   

Abstract

Discriminative stimulus effects of nicotine were evaluated in humans using formal behavioral drug discrimination procedures. Male and female smokers (n = 9 each) were trained on day 1 to reliably discriminate 0 versus 12 micrograms/kg nicotine administered by measured-dose nasal spray. All subjects were able to reach criterion performance (at least 80% correct). Generalization of responding across nicotine doses of 0, 2, 4, 8, and 12 micrograms/kg (approximately 0-0.8 mg for typical subject) was then examined on day 2. Nicotine-appropriate responding was linearly related to dose, and subjects were able to distinguish the smallest dose (2 micrograms/kg) from placebo. Although there were no differences between males and females in behavioral discrimination, subjective effects were correlated with nicotine discrimination in females but not in males. These findings indicate that humans are able to discriminate among low doses of nicotine per se, that males and females may differ in the stimuli used to discriminate nicotine, and that drug discrimination procedures may be more sensitive than traditional subjective effects measures in distinguishing among low doses of nicotine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7701041     DOI: 10.1007/bf02247470

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

Review 1.  Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking.

Authors:  J E Rose; E D Levin
Journal:  Br J Addict       Date:  1991-05

2.  Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.

Authors:  J R Hughes; S W Gust; R M Keenan; J W Fenwick
Journal:  J Pharmacol Exp Ther       Date:  1990-03       Impact factor: 4.030

3.  Assessing individual differences in ethanol preference using a cumulative dosing procedure.

Authors:  H DeWit; J Pierri; C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 4.  Gender differences in tobacco use.

Authors:  N E Grunberg; S E Winders; M E Wewers
Journal:  Health Psychol       Date:  1991       Impact factor: 4.267

5.  Chronic and acute tolerance to subjective effects of nicotine.

Authors:  K A Perkins; J E Grobe; L H Epstein; A Caggiula; R L Stiller; R G Jacob
Journal:  Pharmacol Biochem Behav       Date:  1993-06       Impact factor: 3.533

6.  Psychopharmacological studies on nicotine and tobacco smoking in rhesus monkeys.

Authors:  T Yanagita; K Ando; S Kato; K Takada
Journal:  Psychopharmacol Bull       Date:  1983

7.  Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

Authors:  K O Fagerström
Journal:  Addict Behav       Date:  1978       Impact factor: 3.913

8.  Nicotine as a discriminative stimulus: a neurobehavioral approach to studying central cholinergic mechanisms.

Authors:  J A Rosecrans
Journal:  J Subst Abuse       Date:  1989

9.  In a drug discrimination procedure isolation-reared rats generalize to lower doses of cocaine and amphetamine than rats reared in an enriched environment.

Authors:  S C Fowler; J S Johnson; M J Kallman; J R Liou; M C Wilson; A H Hikal
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior.

Authors:  K A Perkins; J E Grobe; R L Stiller; C Fonte; J E Goettler
Journal:  Clin Pharmacol Ther       Date:  1992-12       Impact factor: 6.875

View more
  19 in total

1.  Sex differences in nicotine self-administration in rats during progressive unit dose reduction: implications for nicotine regulation policy.

Authors:  Patricia Grebenstein; Danielle Burroughs; Yan Zhang; Mark G LeSage
Journal:  Pharmacol Biochem Behav       Date:  2013-11-04       Impact factor: 3.533

2.  Effect of high-dose nicotine patch on craving and negative affect leading up to lapse episodes.

Authors:  Stuart G Ferguson; Saul Shiffman
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

3.  Preliminary test of cigarette nicotine discrimination threshold in non-dependent versus dependent smokers.

Authors:  Kenneth A Perkins; Nicole Kunkle; Joshua L Karelitz; K A Perkins; N Kunkle; J L Karelitz
Journal:  Drug Alcohol Depend       Date:  2017-03-23       Impact factor: 4.492

4.  Assessing Discrimination of Nicotine in Humans Via Cigarette Smoking.

Authors:  Kenneth A Perkins; Nicole Kunkle; Valerie C Michael; Joshua L Karelitz; Eric C Donny
Journal:  Nicotine Tob Res       Date:  2016-03-24       Impact factor: 4.244

5.  Sex differences in hormonal responses to stress and smoking relapse: a prospective examination.

Authors:  Mustafa al'Absi; Motohiro Nakajima; Sharon Allen; Andrine Lemieux; Dorothy Hatsukami
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

Review 6.  Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.

Authors:  J E Henningfield; N L Benowitz; J Slade; T P Houston; R M Davis; S D Deitchman
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

7.  Influence of training dose on nicotine discrimination in humans.

Authors:  K A Perkins; D D'Amico; M Sanders; J E Grobe; A Wilson; R L Stiller
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

8.  Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.

Authors:  Mehmet Sofuoglu; Aryeh I Herman; Marc Mooney; Andrew J Waters
Journal:  Psychopharmacology (Berl)       Date:  2009-08-20       Impact factor: 4.530

Review 9.  Do smokers self-administer pure nicotine? A review of the evidence.

Authors:  Reuven Dar; Hanan Frenk
Journal:  Psychopharmacology (Berl)       Date:  2004-03-05       Impact factor: 4.530

10.  Cigarette abstinence impairs memory and metacognition despite administration of 2 mg nicotine gum.

Authors:  William L Kelemen; Erika K Fulton
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.